Form C-AR — Cytex Therapeutics, Inc.
0001665160-23-001128 · filed May 1, 2023
Offering
- Target
- —
- Maximum
- —
- Security type
- —
- Price per security
- —
- Deadline
- —
- Oversubscription
- —
Issuer
- CIK
- 1943908
- Entity
- Corporation
- Jurisdiction
- DE
- Address
- 2609 N. DUKE STREET, SUITE 303A
DURHAM, NC 27704 - Phone
- —
Most recent fiscal year financials
- Total assets
- $530,603
- Cash
- —
- Short-term debt
- $193,580
- Long-term debt
- $490,492
- Revenues
- $1,052,219
- COGS
- $731,921
- Taxes paid
- —
- Net income
- $-621,726
Same issuer's Form D filings
-
D · Jan 10, 2025$2M
View the original filing on SEC EDGAR ↗